The world countries are racing each other on the damaged track to hit the finishing line with the discovery of the drug, vaccine or a remedy to combat the spread of the Coronavirus (COVID-19), which has been labeled as a global pandemic. The latest version of the deadliest epidemics had infected millions of people and claimed more than 1,14,000 lives worldwide so far and has been rapidly spreading across more countries. With having no vaccine, the world leaders are unleashing all the possible ways to contain the spread.

The rush to discover the remedy has, on one hand, led to the installations of the extensive researches, on the other hand, made the countries to rely on the alternative medicines. Some are pleading the allied nations to deploy alternative drugs to their countries while the powerful country like the United States had vowed retaliation on India if the latter fails to provide the medicine to the worst-hit country in the world. The United States has surpassed Italy with reaching the highest number of death toll worldwide and it also has the highest number of affected cases becoming the newest hotspot for the virus in the world. 

Although the United States has accelerated its fight against the virus, the surging cases had let the economic superpower to reach out to India to provide the drug 'Hydroxychloroquine' and this is the medicine for which US President Donald Trump vowed retaliation against India while Brazil had borrowed the word from Indian Sanskrit epic Ramayana to plead for this drug from India. India has approved to export the medicines but it has raised a question on why the nations are fighting for 'Hydroxychloroquine' and what has it got? We reached out to the medical experts to understand how helpful the drug would be to tackle the virus.

The medical experts put out the fact that it hasn't proven scientifically that Hydroxychloroquine would cure and contain the spread of the global pandemic. According to the Indian Pharmaceutical Alliance (IPA), India manufactures 70% of the world's supply of Hydroxychloroquine which has been eyed to be the game-changer. Initially, this drug was prescribed to fever then it went on to be the drug to cure Malaria.

The experts claimed that in the absence of the final medical research, the consumption of the drug shouldn't be encouraged. The experts say that people with heart diseases shouldn't intake this medicine and this can largely be used to contain the over-reactions shown by the immune powers in the human body while countering the foreign pathogens.

The experts warned that there are recordings of the people who had died with heart disease after consuming Hydroxychloroquine and the asymptomatic people should avoid taking the medicine. One of the notable specialists in India to deal with the pandemics Dr. Subramanian Swaminathan said that the Centers for Disease Control and Prevention (CDC), which is the US Federal Agency, hadn't recognized the consumption of Hydroxychloroquine and the US-based physician and immunologist Dr. Anthony Fauci, who is also the part of the White House Taskforce to combat the virus, revealed that there is no enough medical evidence on prescribing  Hydroxychloroquine as a cure to Coronavirus. However, Trump has declined Fauci's notion.

Being unproven as a cure to Coronavirus, it becomes imperative that we must review the side effects posed by this drug.  Hydroxychloroquine may harm the nervous and circulatory system of the human body and the medical experts warn that the consumption of the medicine for the disease which it won't cure would have an adverse effect on tackling the spread of Malaria as the people could face more shortages for the medicine during Malaria. Tamil Nadu Director of Drugs Control Siva Balan told us that the department has directed the medical shops and pharmacies not to sell Hydroxychloroquine without prescription and the doctors are not prescribing this drug to treat the virus and the department has called the people not to consume the medicine until its proven. According to the facts, India has accounted for a 47% supply of  Hydroxychloroquine in the US Markets in 2019 and last week the Central Government has decided to export this anti-malaria drug only to foreign governments and not to the private companies as the medicine is under the banned category of exports.